Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

• Status: Completed
• Trial end date: 2006-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Estradiol; Estrogens

Criteria

Inclusion Criteria:

• Atrophic vaginitis due to estrogen deficiency

• Post-menopausal